Skip to main content
Suman Paul, MD, Oncology, Baltimore, MD

SumanPaulMD

Oncology • Baltimore, MD

Physician

Join to view full profile

Dr. Paul is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Paul's full profile

Already have an account?

  • Office

    1800 Orleans Street
    Baltimore, MD 21287
    Phone+1 410-955-5000
    Fax+1 410-955-5001

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2021
  • University of Toledo
    University of ToledoResidency, Internal Medicine, 2013 - 2016
  • University of Calcutta School of Medicine
    University of Calcutta School of MedicineClass of 2007

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2017 - 2025
  • OH State Medical License
    OH State Medical License 2013 - 2018
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Lectures

  • Targeting MHC-linked wild type p53 with TCR mimic single chain diabody for cancer immunotherapy. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Checkpoint Blockade Therapy May Sensitize Hodgkin Lymphoma to Subsequent Therapy 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Checkpoint Blockade Therapy May Sensitize Aggressive and Indolent Non-Hodgkin Lymphoma to Subsequent Therapy 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Characterization of Pathogenic Vibrio Parahaemolyticus Isolated from Fish Aquaculture of the Southwest Coastal Area of Bangladesh
    Characterization of Pathogenic Vibrio Parahaemolyticus Isolated from Fish Aquaculture of the Southwest Coastal Area of BangladeshMarch 8th, 2021
  • Ludwig Johns Hopkins Researchers Devise New Strategy for Cancer Immunotherapy
    Ludwig Johns Hopkins Researchers Devise New Strategy for Cancer ImmunotherapyMarch 2nd, 2021
  • Breakthrough in Controlling T Cell Activation
    Breakthrough in Controlling T Cell ActivationMay 13th, 2014
  • Join now to see all

Dr. Suman Paul, Dr. Suman Paul, MD, Dr. S Paul